Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
5 Patents
#292 in St. Louis, MO
#729 in Missouri
#51,620 in US
Fimbrion Therapeutics, Inc.
Forward Citations = 8
7 inventors:
St. Louis, MO, United States of America
Fimbrion Therapeutics, Inc.
EPO Patents = 1
Forward Citations = 8
Loading Chart...
Loading Chart...
7 inventors (with patents filed for the assignee):
James Walter Janetka (5 out of 32 patents)
Katherine Louisa Widdowson (4 out of 7 patents)
Michael Joseph Bishop (4 out of 11 patents)
4. Eugene L Stewart (3 out of 5 patents)
5. Laurel Kathryn McGrane (2 out of 3 patents)
6. Laurel Kathryn Mcgrane (2 out of 2 patents)
7. Laurel Mydock-McGrane (1 out of 1 patent)
8. Vincent J Colandrea (1 patent)
9. Yuehu Li (1 patent)
10. Iulia Strambeanu (0 patent)
5 patents:
1. 12351597 - Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH (2025-07-08),
3. 11697665 - C-mannoside compounds useful for the treatment of urinary tract infections (2023-07-11),
Company Overview
Fimbrion Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for patients with serious diseases. The company specializes in harnessing the power of its proprietary technology platform to create novel treatments that target unmet medical needs. With a commitment to advancing healthcare, Fimbrion aims to improve patient outcomes through its research and development efforts in various therapeutic areas.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fimbrion Therapeutics, Inc.. Retrieved from https://idiyas.com/company/fimbrion-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]